-
MiTAC Computing Showcases Full-Stack Innovation to Scale Open AI Infrastructure at OCP Global Summit 2026
-
2026 World Trade Centers Association Member Forum to Convene Global Network to Shape What's Next for Global Business
-
HARTING Joins NVIDIA MGX Ecosystem to Power Next-Generation AI Infrastructure
-
Saksoft Appoints Gurmeet Chahal as Chief Executive Officer to Lead Its Next Phase of Global Scale and AI-Led Transformation
-
Optro Unveils 2026 Connector Award Winners Recognizing Leaders in GRC Intelligence and AI Innovation
-
Cellid Joins Qualcomm's the Snapdragon START program to accelerate the development of AR glasses
-
XPENG Launches the G9L Next-Gen AI Flagship SUV in Europe, Debuts NGP and Expands Global Technology Collaboration at 2026 Paris Motor Show
-
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.03 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $16.2 Billion
Paradigm Therapeutics, Inc. Nominated for the Second Straight Year for the Prestigious 2026 Prix Galien USA "Best Start-Up" Award for SD-101 (Zorblesia™), a Topical Therapy for Treating the Entire Skin Surface of Patients with Epidermolysis Bullosa (EB)
SD-101 (Zorblesia™) is the First Topical Therapy Developed to Treat Wounds and…